Vigilancia de laboratorio de Streptococcus pneumoniae procedente de enfermedad invasora, Chile 2007-2012

Valenzuela, M. Teresa; Seoane, Mabel; Canals, Andrea; Pidal, Paola; Hormazábal, Juan C; Araya, Pamela; Terrazas, Solana; Díaz, Janepsy.
Rev. chil. infectol ; 31(6): 651-658, dic. 2014. graf, tab
Artigo em Espanhol | LILACS | ID: lil-734756

Documentos relacionados

  1. [Laboratory surveillance of Streptococcus pneumoniae from invasive disease, Chile 2007-2012].
  2. Invasive pneumococcal surveillance to assess the potential benefits of extended spectrum conjugate vaccines (PCV15/PCV20) in older adults.
  3. Characterization of pneumococcal serotype 7F in vaccine conjugation.
  4. A Nationwide Outbreak of Invasive Pneumococcal Disease in Israel Caused by Streptococcus pneumoniae Serotype 2.
  5. Challenges in Inferring Pneumococcal Conjugate Vaccine Impact From Bacterial Surveillance Data.
  6. Distribution of Serotypes Causing Invasive Pneumococcal Disease in Children From High-Income Countries and the Impact of Pediatric Pneumococcal Vaccination.
  7. Post-13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children of Serotypes Included in Candidate Extended-Spectrum Conjugate Vaccines.
  8. Pneumococcal Surface Protein A: A Promising Candidate for the Next Generation of Pneumococcal Vaccines.
  9. Comparison of PCV10, PCV13, PCV15, PCV20 and PPSV23 vaccine coverage of invasive Streptococcus pneumoniae isolate serotypes in Canada: the SAVE study, 2011-20.
  10. Strengths and weaknesses of pneumococcal conjugate vaccines.